4.7 Article

Antiviral cyclic D,L-α-peptides:: Targeting a general biochemical pathway in virus infections

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 13, Issue 17, Pages 5145-5153

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2005.05.051

Keywords

cyclic peptide; antiviral; adenovirus; influenza

Funding

  1. NEI NIH HHS [EY11431, R01 EY011431] Funding Source: Medline
  2. NHLBI NIH HHS [HL54352, R01 HL054352] Funding Source: Medline
  3. NIAID NIH HHS [AI007354, T32 AI007354] Funding Source: Medline
  4. NIGMS NIH HHS [R01 GM052190] Funding Source: Medline

Ask authors/readers for more resources

Diverse virus families have evolved to exploit the acidification of endosomal compartments to gain entry into cells. We describe a supramolecular approach for selectively targeting and inhibiting viral infections through this central biochemical pathway. Using adenovirus as a model non-enveloped virus, we have determined that an eight-residue Cyclic D,L-alpha-peptide, selected from a directed combinatorial library, can specifically prevent the development of low pH in endocytic vesicles, arrest the escape of virions from the endosome, and abrogate adenovirus infection without an apparent adverse effect on cell viability. The likely generality of this approach against other pH-dependent viral infections is supported by the inhibition of type-A influenza virus escape from endosomes in the presence of the same peptide. Our studies suggest that self-assembling Cyclic D,L-alpha-peptides hold considerable potential as a new rational supramolecular approach toward the design and discovery of broad-spectrum antiviral agents. (c) 2005 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available